コンテンツにジャンプ

トップページ > 組織情報 > 局員紹介 > 永井真理 ナガイ マリ / Mari NAGAI

永井真理 ナガイ マリ / Mari NAGAI

2023.09更新

nagai_mari.jpg

国際医療協力局
連携協力部 展開支援課
展開支援専門職
MD, MPH, PhD

専門分野

国際保健、保健システム強化(とくに保健医療人材を通じてのユニバーサルヘルスカバレッジ)、リプロダクティブヘルス、総合内科専門医

海外活動歴(長期派遣のみ、NCGM就職前含む)

1999年 9月 - 2000年 5月 国境なき医師団(スリランカ)医師

2000年 9月 - 2001年 5月 国境なき医師団(イラン) プロジェクトリーダー

2002年 10月- 2003年 5月 日本医療救援機構(アフガニスタン) プロジェクトリーダー

2007年 2月 ‐ 2008年 3月 JICA (カンボジア) 地域の母子保健システム強化専門家

2011年 4月 - 2014年 4月 JICA(セネガル)  保健省官房顧問

2015年 3月 - 2018年 5月 WHO(フィリピン)西太平洋地域事務局 リプロダクティブヘルス・母子保健 技官

国際的な委員等

2011年 -
2014年
世界エイズ・結核・マラリア対策基金(ジュネーブ)技術審査委員

2018年 -
2022年 
世界エイズ・結核・マラリア対策基金(ジュネーブ)技術評価委員

2022年 - WHO 避妊具使用の医学的な適格基準と実践の推奨策定委員
2023年 - WHO本部「ケアバンドルを用いた産後出血の診断と治療」に関するガイドライン策定委員

2023年 -
2026年

WHO 西太平洋地域事務局 ユニバーサル・ヘルス・カバレッジ技術諮問委員

メッセージ

どこで生まれてもどこに住んでいても、その人が心も身体も満たされた状態で社会生活を送れるよう、制度・仕組みに働きかけるのが仕事です。地味に地道に、日々、小さな貢献ができることに、喜びを感じています。

出版物リスト(論文、著書など):英文論文

  1. Thandar M, Obaidur R Md , Haruyama R , Matsuoka S, Okawa S, Moriyama J, Yokobori Y, Matsubara C, Nagai M, Ota E ,Baba T: Effectiveness of infection control teams in reducing healthcare-associated infections: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health ;2022;19:17075 
    https://doi.org/10.3390/ijerph192417075
  2. Honda M, Inoue N, Liverani M, et Nagai M: Lessons learned from the history of postgraduate medical training in Japan:from disease‑centred care to patient‑centred care in an aging society. Human Resources for Health; 2022;20:54 
    https://doi.org/10.1186/s12960-022-00752-x
  3. T Kitamura, H Obara, M Honda, T Mori, T Ito, M Nagai, S Rattana, T Rathavy, Y Sugiura. : Early essential newborn care in national tertiary hospitals in Cambodia and Lao People’s Democratic Republic: a cross‑sectional study. BMC Pregnancy and Childbirth 2022; 22:745
    https://doi.org/10.1186/s12884-022-05056-5
  4. A. D Weeks, O.I.Akinola, M. Amorim, B. Carvalho, C. Deneux-Tharaux, T. Liabsuetrakul, M. Meremikwu, S. Miller, A. Nabhan, M Nagai, H. Wahabi, D.Walker.: World Health Organization recommendation for using uterine balloon tamponade to treat postpartum hemorrhage. Obstet Gynecol. 2022;139(3):458-462.
    https://doi.org/10.1097/aog.0000000000004674
  5. Fujita M, Matsuoka S, Kiyohara H, Nagai M, Hachiya M,Fujita N et al: “Staying at home” to tackle COVID-19 pandemic: Rhetoric or Reality? Cross-cutting analysis of nine population groups vulnerable to homelessness in Japan. Tropical Medicine and Health; 2020;48(92) 
    http://dx.doi.org/10.1186/s41182-020-00281-0
  6. Nagai M, Oikawa M, Tamura T, Egami Y, Fujita N: Can we apply lessons learned from Ebola experience in West Africa for COVID-19 in lower income countries? Global Health & Medicine; 2020; 2(2):140-141 
    https://doi.org/10.35772/ghm.2020.01028
  7. Nagai M, Bellizzi S, Murray J, Kitong J, Cabral E, Howard S. : Opportunities lost: Barriers to increasing the use of effective contraception in the Philippines. PLoS ONE ;2019: 14(7): e0218187. 
    https://doi.org/10.1371/journal.pone.0218187
  8. Xu T, Tomokawa S, Gregorio ER Jr, Mannava P, Nagai M, Sobel H. School-based interventions to promote adolescent health: A systematic review in low- and middle-income countries of WHO Western Pacific Region. PLoS One;2020 ;15(3):e0230046
    https://doi.org/10.1371/journal.pone.0230046
  9. COVID-19 Research Prioritization Group on MNCAH.: Global research priorities on COVID-19 for maternal, newborn, child and adolescent health. J Glob Health 2021;11:05026 
    https://doi.org/10.7189/jogh.11.04071
  10. Honda A, Krucien N, Ryan M, Diouf I, Salla M, Nagai M,Fujita N: For more than money: willingness of health professionals to stay in remote Senegal. Human Resources for Health; 2019; 17 (28) 
    https://doi.org/10.1186/s12960-019-0363-7
  11. Bellizzi S, Mannava P, Nagai M, Sobel H.: Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries. Contraception. 2019; 101(1). 
    https://doi.org/10.1016/j.contraception.2019.09.006
  12. Zhang L, Tao Y , Woodring J , Rattana K, Sovannarith S, Rathavy T, Cheang K, Hossain S, Ferradini L, Deng S, Sokun C, Samnang C, Nagai M, Ru Lo Y, Ishikawa N. Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation. International Journal of Epidemiology;2019: 48(4) 
    https://doi.org/10.1093/ije/dyz037
  13. Kojo T, Nagai M, Salla M, Diouf I, Fujita N: Retention of qualified health professionals in rural areas: a case control study. Africa Health; 2018; 40 (4); 21-25 
  14. Woodring J, Ishikawa N, Nagai M, et al. : Integrating HIV, hepatitis B and syphilis screening and treatment through the maternal, newborn and child health platform to reach global elimination targets. WPSAR;2017; 8(4) 
  15. Nagai M, Fujita N, IS Diouf, M Salla: Retention of qualified health workers in rural Senegal: lessons learned from a qualitative study. Rural and Remote Health; 2017;4149
    https://doi.org/10.22605/rrh4149
  16. Fujita N, Nagai M, et al.: The role of a network of human resources for health managers in supporting leadership for health systems strengthening in Francophone African countries. Health Systems & Reform; 2016
    https://doi.org/10.1080/23288604.2016.1220778
  17. Matsuoka S, Obara H, Nagai M, Murakami H, Chan Lon R. Performance-based financing with GAVI health system strengthening funding in rural Cambodia: a brief assessment of the impact. Health Policy and Planning; 2013; 29(4);456-465.
    https://doi.org/10.1093/heapol/czt030
  18. Kitamura T, Obara H, Takashima Y, Takahashi K, Inaoka K, Nagai M, Endo H, Jimba M, Sugiura Y . World Health Assembly Agendas and trends of international health issues for the last 43 years: Analysis of World Health Assembly Agendas between 1970 and 2012. Health Policy; 2013; 110: 198-206. 
    https://doi.org/10.1016/j.healthpol.2012.12.008
  19. Fujita N, Zwi A, Nagai M, Akashi H. A comprehensive framework for human resources for health system development in fragile and post-conflict states. PLoS Med 2011, 8(12):e1001146.
    https://doi.org/10.1371/journal.pmed.1001146
  20. Nagai M, Karunakara U, Rowley E, Burnham G. Violence against refugees, non-refugees and host populations in southern Sudan and northern Uganda. Global Public Health 2008;3(3):249-270.
    https://doi.org/10.1080/17441690701768904
  21. Nagai M, Sandirasegaram A, Okamotoa M, Kita E, Aoyama A. Reconstruction of health service systems in the post-conflict Northern Province in Sri Lanka. Health Policy 2007; 83: 84-93.
    https://doi.org/10.1016/j.healthpol.2006.12.001

出版物リスト(論文、著書など):英文書籍

  1. Global Fund. Technical Evaluation Reference Group. Thematic Evaluation of Accelerating the Equitable Deployment of and Access to Innovations. Geneva, 20200
  2. Global Fund. Technical Evaluation Reference Group. Thematic Evaluation of the wambo.org pilot for non-Global Fund financed orders. Geneva, 2022
  3. Global Fund. Technical Evaluation Reference Group. Thematic Evaluation of the Global Fund’s Performance in Challenging Operating Environments (COE). Geneva, 2022
  4. World Health Organization Department of Sexual and Reproductive Health and Research (WHO/SRH) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge SUCCESS. Family Planning: A Global Handbook for Providers (2022 update). Baltimore and Geneva: CCP and WHO; 2022.
  5. Global Fund. Technical Evaluation Reference Group. Thematic Review of Tuberculosis Prevention. Geneva, 2022
  6. Global Fund. Technical Evaluation Reference Group. Thematic Review of Strategic Initiatives. Geneva, 2022
  7. Global Fund. Technical Evaluation Reference Group. Thematic Review of Multi-Country Catalytic Investment Grants. Geneva, 2022
  8. Global Fund. Technical Evaluation Reference Group. Thematic Review of Global Heath Security (Pandemic Preparedness and Response) – Secretariat-led with TERG oversight. Geneva, 2022
  9. Global Fund. Technical Evaluation Reference Group. Prospective Country Evaluation Extension Synthesis Report. Geneva, 2022
  10. Global Fund. Technical Evaluation Reference Group. Thematic Review of HIV Primary prevention. Geneva, 2021
  11. Global Fund. Technical Evaluation Reference Group Position Paper: Prospective Country Evaluations. Geneva, 2021
  12. Global Fund. Technical Evaluation Reference Group Position Paper: Prospective Country Evaluations. Geneva, 2021
  13. Global Fund. Technical Evaluation Reference Group. Thematic Review on the Role of the Private Sector in Program Delivery. Geneva, 2021
  14. World Health Organization. WHO recommendation on uterine balloon tamponade for the treatment of postpartum hemorrhage. Geneva. 2021.
  15. World Health Organization. Regional Office for the Western Pacific. Meeting Report for the virtual Expert Consultation on Viral Hepatitis Elimination in the Western Pacific Region. 2020.
  16. Global Fund. Technical Evaluation Reference Group Position Paper: Strategic Review 2020. Geneva. 2020
  17. World Health Organization. WHO recommendation on routes of oxytocin administration for the prevention of postpartum hemorrhage after vaginal birth. Geneva. 2020
  18. World Health Organization. WHO recommendation on umbilical vein injection of oxytocin for the treatment of retained placenta. Geneva. 2020
  19. World Health Organization. WHO recommendation on advance misoprostol distribution to pregnant women for prevention of postpartum hemorrhage. Geneva. 2020
  20. Global Fund. Thematic Review on Sustainability, Transition and Co-Financing Policy. Geneva. 2020
  21. Global Fund. Thematic Review of Marketing Shaping Strategy (Mid-Term). Geneva. 2019
  22. Global Fund. Thematic review of the Global Fund country level technical support partnership model. Geneva. 2019
  23. Global Fund. Thematic review of resilient and sustainable systems for health. Geneva. 2019
  24. World Health Organization. Contraceptive eligibility for women at high risk of HIV. Guidance statement: recommendations on contraceptive methods used by women at high risk of HIV. Geneva. 2019
  25. World Health Organization. WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections. Geneva. 2018
  26. World Health Organization. WHO recommendations: Intrapartum care for a positive pregnancy experience (2018).
  27. World Health Organization. Regional Office for the Western Pacific. Introducing and sustaining EENC in hospitals: kangaroo mother care for pre-term and low-birthweight infants. (Early Essential Newborn Care, Module 4). (2018).
  28. World Health Organization. Regional Office for the Western Pacific. Second biennial progress report 2016- 2017. (2018)
  29. World Health Organization. Regional Office for the Western Pacific. Maternal Health Care: Policies, Technical Standards and Service Accessibility in Eight Countries in the Western Pacific Region (2018)
  30. World Health Organization. Regional Office for the Western Pacific. Prevent unwanted pregnancy: An infographic on the most effective types of contraception (2018)
  31. World Health Organization. Regional Office for the Western Pacific. Annual implementation review and planning guide (Early Essential Newborn Care, Module 1). (2018).
  32. World Health Organization. Regional Office for the Western Pacific. Prevent unwanted pregnancy: Abortion in the Western Pacific Region. Infographics (2017)
  33. World Health Organization. Regional Office for the Western Pacific. Papua New Guinea : actions for scaling up long-acting reversible contraception
  34. World Health Organization. Regional Office for the Western Pacific. Cambodia : Identifying actions for scaling up long-acting reversible contraception
  35. World Health Organization. Regional Office for the Western Pacific. Expert consultation on triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis in the Western Pacific (2017)
  36. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience (2016). Name is mentioned in the document
  37. Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division (2016).
  38. Office for the Western Pacific. First biennial progress report: action plan for healthy newborn infants in the Western Pacific Region (2014-2020) (2016)
  39. World Health Organization. Regional Office for the Western Pacific. Introducing and sustaining EENC in hospitals: Routine childbirth and newborn care (2016)
  40. World Health Organization. Regional Office for the Western Pacific. Coaching guide for the first embrace: facilitator’s guide (Early Essential Newborn Care) (2016)

出版物リスト(論文、著書など):和文論文

  1. 永井真理 生まれた瞬間からすべての赤ちゃんに必要なケアを 小児内科 2016: 48(2):261-264
  2. 井戸田一朗、永井真理世界結核・エイズ・マラリア対策基金の現在 The Journal of AIDS Research 2014 ;16(2):70-76 
  3. 田村豊光,藤田則子,永井真理,清水孝行,池田憲昭。日本での研修から地域ネットワーク構築への展開―仏語圏アフリカ保健人材管理研修の経験から 保健医療科学 2013;62(5):488-493.
  4. 藤田則子、後藤美穂、松本安代、永井真理、堀越洋一、杉浦康夫、三好知明、仲佐保。仏語圏アフリカ諸国を対象とした母子保健集団研修の経験から効果的な研修のあり方を考える(2) 研修終了時に作成した活動計画実施に向けた課題とフォロアップによる介入国際保健医療,2010; 25 (2): 89-97 
  5. 永井真理、後藤美穂、松本安代、藤田則子、堀越洋一、杉浦康夫、三好知明、仲佐保。仏語圏アフリカ諸国を対象とした母子保健集団研修の経験から効果的な研修のあり方を考える(1) 発言記録を利用した研修モニタリング評価国際保健医療, 2010; 25 (1) : 47-57 
  6. 永井真理、木下真里、青山温子。イラクにおける女性医師の状況について-エジプトでの国外研修参加者に対する面接結果より- 国際保健医療 2007; 22 (1): 53-63 
  7. 吉崎基弥、青山温子、永井真理、小林明子。カンボジアにおける身体障害者支援の現状と課題。国際保健医療 2006;21:43-51 

翻訳

  1. 駒形朋子、田村豊光、永井真理. 看護と助産のグローバル戦略の方向性2021-2025. Global strategic directions for NURSING AND MIDWIFERY 2021-2025, World Health Organization, 2021
  2. 駒形朋子、田村豊光、永井真理. 世界の看護2020 教育、労働、リーダーシップへの投資 STATE OF THE WORLD'S NURSING 2020, World Health Organization, 2020
  3. 分娩期ケアガイドライン翻訳チーム、永井真理(翻訳協力). WHO推奨ポジティブな出産経験のための分娩期ケア.医学書院、2021.